Recurrent Hepatitis C Virus (Genotype 4) Infection After Living Donor Liver Transplantation: Risk Factors and Outcome

Journal of Liver
doi 10.4172/2167-0889.1000148
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Epidemiology and Risk Factors for Infection After Living Donor Liver Transplantation

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Outcomes in Hepatitis C Virus–infected Recipients of Living Donor vs. Deceased Donor Liver Transplantation

Liver Transplantation
HepatologyTransplantationSurgery
2006English

Hepatitis C Virus Recurrence After Liver Transplantation

Gut
Gastroenterology
1999English

Very Late Relapse of Hepatitis C Virus Infection Immediately After Liver Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2016English

Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Preventable Problem or an Acceptable Risk?

Annals of Surgical Oncology
OncologySurgery
2010English

Prevention of De Novo Hepatitis B Virus Infection in Living Donor Liver Transplantation Using Hepatitis B Core Antibody Positive Donors

Clinical Transplantation
Transplantation
2002English

Living Donor Liver Transplantation

Chirurgia (Bucharest, Romania : 1990)
Surgery
2017English

Pre Transplant Serum Magnesium Level Predicts Outcome After Pediatric Living Donor Liver Transplantation

Annals of Transplantation
MedicineTransplantation
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy